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Abstract: The spinal dorsal horn harbors a sophisticated and heterogeneous network of excitatory and
inhibitory neurons that process peripheral signals encoding different sensory modalities. Although it has
long been recognized that this network is crucial both for the separation and the integration of sensory
signals of different modalities, a systematic unbiased approach to the use of specific neuromodulatory
systems is still missing. Here, we have used the translating ribosome affinity purification (TRAP) tech-
nique to map the translatomes of excitatory glutamatergic (vGluT2+) and inhibitory GABA and/or
glycinergic (vGAT+ or Gad67+) neurons of the mouse spinal cord. Our analyses demonstrate that in-
hibitory and excitatory neurons are not only set apart, as expected, by the expression of genes related
to the production, release or re-uptake of their principal neurotransmitters and by genes encoding for
transcription factors, but also by a differential engagement of neuromodulator, especially neuropeptide,
signaling pathways. Subsequent multiplex in situ hybridization revealed eleven neuropeptide genes that
are strongly enriched in excitatory dorsal horn neurons and display largely non-overlapping expression
patterns closely adhering to the laminar and presumably also functional organization of the spinal cord
grey matter.
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Neuron‑specific spinal cord 
translatomes reveal a neuropeptide 
code for mouse dorsal horn 
excitatory neurons
Rebecca Rani Das Gupta1,2, Louis Scheurer1, Pawel Pelczar3, Hendrik Wildner1* & 
Hanns Ulrich Zeilhofer1,2*
The spinal dorsal horn harbors a sophisticated and heterogeneous network of excitatory and inhibitory 
neurons that process peripheral signals encoding different sensory modalities. Although it has long 
been recognized that this network is crucial both for the separation and the integration of sensory 
signals of different modalities, a systematic unbiased approach to the use of specific neuromodulatory 
systems is still missing. Here, we have used the translating ribosome affinity purification (TRAP) 
technique to map the translatomes of excitatory glutamatergic  (vGluT2+) and inhibitory GABA 
and/or glycinergic (vGAT + or  Gad67+) neurons of the mouse spinal cord. Our analyses demonstrate 
that inhibitory and excitatory neurons are not only set apart, as expected, by the expression of 
genes related to the production, release or re‑uptake of their principal neurotransmitters and by 
genes encoding for transcription factors, but also by a differential engagement of neuromodulator, 
especially neuropeptide, signaling pathways. Subsequent multiplex in situ hybridization revealed 
eleven neuropeptide genes that are strongly enriched in excitatory dorsal horn neurons and display 
largely non‑overlapping expression patterns closely adhering to the laminar and presumably also 
functional organization of the spinal cord grey matter.
The ability to sense and discriminate different noxious and innocuous somatosensory stimuli is essential for 
all higher animals and humans in order to react adequately to external stimuli and internal  conditions1,2. The 
spinal dorsal horn, i.e., the sensory part of the spinal cord, constitutes a key element in this process. It receives 
somatosensory signals from peripheral neurons and processes these signals together with other inputs descend-
ing from supraspinal sites in a complex network of inhibitory and excitatory interneurons before relaying them 
via projection neurons to supraspinal  centers3. Projection neurons make up less than 10% of all dorsal horn 
neurons, while more than 90% of the neuronal population are interneurons of which, between 60 and 70% are 
excitatory glutamatergic neurons, and the rest is inhibitory (GABA and/or glycinergic)3,4. Besides these prin-
cipal neurotransmitters, many neurons of the spinal dorsal horn use additional signaling molecules, especially 
neuropeptides, for neuronal communication, which together with the structural connectivity set the basis for 
modality specific sensory processing.
The spinal cord is organized in a laminar fashion, which has initially been proposed on the basis of differences 
in cell density and  morphology5,6 but has later been shown to also reflect a functional organization. This becomes 
obvious especially from the lamina specific innervation pattern by the different types of peripheral sensory neu-
rons: unmyelinated C fibers, which mainly carry noxious and thermal information, terminate in the superficial 
dorsal horn (laminae I–II), while thickly myelinated Aβ fibers, which convey innocuous signals including touch 
and proprioceptive information, terminate in the deep dorsal horn (laminae III–V)3,7,8. A laminar organiza-
tion of neuronal function is also supported by gene expression patterns that follow laminar  patterns9–13 and a 
recent publication indicating a topographic map for spinal sensorimotor  reflexes14. Furthermore, optogenetic 
and chemogenetic experiments support a modality-specific processing by distinct genetically defined neuron 
 populations8,15–17. However, the basis of this modality specific processing beyond structural connectivity is only 
incompletely understood.
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In the present study, we performed a genome-wide unbiased search for genes involved in neuronal com-
munication in excitatory or inhibitory spinal cord neurons. To this end, we employed the translating ribosome 
affinity purification (TRAP)  technology18 to characterize the translatomes (i.e. the whole range of mRNAs that are 
not only transcribed but also translated). We generated vGluT2::bacTRAP (Slc17a6), vGAT::bacTRAP (Slc32a1) 
and Gad67::bacTRAP (Gad1) mice, which express the eGFP-tagged ribosomal subunit L10a (RPL10a) under the 
control of the respective gene regulatory elements. Gene ontology and pathway analyses revealed that, in addition 
to transcription factors and genes related to the neurotransmitter phenotype of these neurons, genes encoding 
elements of neuropeptide signaling constitute a functionally defined class of genes that is highly enriched in 
excitatory spinal neurons. About 25% of the most strongly enriched genes were neuropeptides. Subsequent 
multiplex in situ hybridization for neuropeptide encoding genes revealed largely non-overlapping expression 
patterns that follow the laminar organization of the spinal cord thus suggesting a role of neuropeptide signaling 
in segregation of sensory modalities.
Results
Generation and validation of three bacTRAP mouse lines to profile gene translation in excita‑
tory and inhibitory neurons. In this study, we set out to investigate the neuron type- and potentially 
lamina-specific use of neuromodulator systems in dorsal horn neurons. As part of an unbiased genome wide 
approach we analyzed the translatomes (polysome-bound mRNA) of excitatory and inhibitory neurons of the 
mouse spinal cord. To this end, we generated three bacTRAP mouse lines; vGluT2::bacTRAP (Tg(Slc17a6-
RPL10a-eGFP)Uze), Gad67::bacTRAP (Tg(Gad1-RPL10a-eGFP)Uze) and vGAT::bacTRAP mice (Tg(Slc32a1-
RPL10a-eGFP)Uze). In these mice, the eGFP-tagged ribosomal protein L10a is expressed as a transgene either 
in glutamatergic neurons (vGluT2::bacTRAP (Fig. 1A,D,G), all inhibitory neurons (GABAergic and glyciner-
gic neurons) (vGAT::bacTRAP, Fig. 1B,E,H) or in GABAergic neurons that utilize Gad67 for GABA synthesis 
(Gad67::bacTRAP, Fig. 1C,F,I).
From the spinal cord of these mice, polysome-bound mRNA can be isolated by co-immunoprecipitation 
of mRNA bound to the eGFP-L10a tagged ribosomes. We confirmed the correct expression of the eGFP-L10a 
transgene in the lumbar spinal cord of the different mouse strains by immunohistochemistry. NeuN was used as 
a neuronal marker, Pax2 as a ubiquitous marker for spinal  inhibitory19,20 and Lmx1b as a marker for the major-
ity of dorsal spinal excitatory neurons (Fig. 1D–I). In the vGluT2::bacTRAP line, the eGFP-L10a expression 
is restricted to Pax2-negative neurons (98.8 ± 0.5%  Pax2−  NeuN+; Fig. 1D,G,J), indicating its exclusive expres-
sion in excitatory spinal neurons. In the two mouse lines targeting inhibitory neurons, vGAT::bacTRAP and 
Gad67::bacTRAP, the expression was confined to Pax2-positive neurons (98.3 ± 0.8%, 97.4 ± 1.6%, respectively) 
and virtually absent from excitatory, Lmx1b-positive neurons of the dorsal horn (0.25 ± 0.22%, 0.19 ± 0.34%, for 
vGAT::bacTRAP and Gad67::bacTRAP mice, respectively; Fig. 1E,F,H,I,K,L). Next, we determined the fraction 
of vGluT2, vGat and Gad67 mRNA expressing neurons that co-express the eGFP-L10a (TRAP) transgene in the 
respective TRAP driver line. To this end, we performed multiplex in situ hybridizations on lumbar spinal cord 
sections of Gad67::bacTRAP, vGAT::bacTRAP and vGluT2::bacTRAP mice (Fig. S1). 96.5 ± 3% of Gad67 + neu-
rons (Fig. S1A–C), 93.8 ± 4% of vGAT neurons (Fig. S1D–F) and 95.4 ± 1.2% of vGluT2 neurons (Fig. S1G–I) 
expressed the TRAP transgene in the respective mouse line. To further validate the three bacTRAP lines we 
isolated the mRNA bound to the eGFP-L10a tagged ribosomes from each line and analyzed the enrichment of 
selected marker genes in the polysome pull down fraction versus the input using qPCR. In all cases, we found 
an enrichment of the transcript encoding the transgene (eGFP) (Fig. 1M–O). In addition, when comparing the 
pull down fraction versus the input fraction isolated from the vGluT2::bacTRAP line we found an enrichment 
of transcripts encoding excitatory markers (Lmx1b and vGluT2) and a depletion of the transcripts encoding 
for inhibitory markers (vGAT , GlyT2 and Gad1) (Fig. 1O). Conversely, in the two lines expressing the TRAP 
construct in inhibitory neurons we found an enrichment of vGAT, GlyT2 and Gad1 and a depletion of Lmx1b 
and vGluT2 (Fig. 1N,M).
Figure 1.  Generation and validation of three bacTRAP mouse lines, specific to excitatory and inhibitory spinal 
cord neurons. (A,D,G,J) vGluT2::bacTRAP line, (B,E,H,K) vGAT::bacTRAP line, (C,F,I,L) Gad67::bacTRAP 
line. (A–C) BAC constructs for the three mouse lines. (D–I) Immunofluorescence images of the lumbar 
spinal dorsal horn of the three mouse lines. Boxes in the overview images of (D–F) indicate the position of 
the higher magnification images in (G–H). (D,G) vGluT2::bacTRAP line with eGFP in green, Pax2 in red 
and NeuN in blue. (E,H) vGAT::bacTRAP mouse line with eGFP in green, Pax2 in red and Lmx1b in blue. 
(F,I) Gad67::bacTRAP mouse line with eGFP in green, Pax2 in red and Lmx1b in blue. (J) Quantification 
of eGFP+NeuN+ cells with and without signal for Pax2 in the vGluT2::bacTRAP line. (K,L) Quantification 
of eGFP + cells with signal for Pax2 or Lmx1b in (K) the vGAT::bacTRAP line and (L) the Gad67::bacTRAP 
line. (M–O) RT-PCR based quantification of the enrichment of selected genes comparing the polysome 
bound fraction to the input. (M) Enrichment of eGFP (10.5 fold ± 1.6), Lmx1b (2.8 fold ± 0.3) and vGluT2 (4.3 
fold ± 0.3) and depletion of vGAT (− 4.9 fold ± 1.5), GlyT2 (− 5.1 fold ± 1.9) and Gad1 (− 4-fold ± 1.2) after 
polysome purification from vGluT2::bacTRAP mice is depicted. (N) Enrichment of eGFP (23.4 fold ± 5.3), 
vGAT (8.2fold ± 2.4), GlyT2 (5.6 fold ± 1.7) and Gad1 (9.4 fold ± 2.5) and depletion of Lmx1b (− 4.5 fold ± 0.4) 
and vGluT2 (− 9.3 ± 4.7) after polysome purification from vGAT::bacTRAP mice is depicted. (O) Enrichment of 
eGFP (19.6 fold ± 1.1), vGAT (5.625 fold ± 0.3), GlyT2 (3.4 fold ± 0.2) and Gad1 (10.2fold ± 0.6) and depletion of 
Lmx1b (− 5-fold ± 0.3) and vGluT2 (− 6.8 fold ± 0.4) after polysome purification from Gad67::bacTRAP mice is 
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General differences in gene expression in excitatory and inhibitory spinal neurons. Next, we 
used the bacTRAP mouse lines to identify key features and subtype specific markers of the two main subpopu-
lations of spinal interneurons (i.e. excitatory or inhibitory dorsal horn neurons). To this end, we isolated and 
sequenced the cell-type-specific polysomal mRNA from the lumbar spinal cord of three animals from each 
mouse line. Out of 22,880 detectable genes, between 13,515 and 13,774 were found expressed in each mouse line 
(Fig. 2A, Table S1), defined by a normalized count (number of reads per gene, normalized to the total number 
of reads and the gene length) of > 10. Table S1 thus presents the first source of a browsable genome wide atlas 
of translated mRNAs in excitatory and inhibitory spinal neurons. In order to identify those genes that show a 
regionally non-overlapping expression pattern, we focused our analyses on genes whose regional expression was 
accessible by in situ hybridization. To this end, we assumed that genes with normalized counts > 100 should be 
reliably detectable with in situ hybridization. This threshold is three times lower than the expression of Grpr, a 
gene that we previously found expressed at low levels in a small subset of dorsal horn neurons. In all three mouse 
lines, approximately 11,200 genes were expressed at levels exceeding this threshold (Fig. 2A). Differential gene 
expression analyses (DGEAs) revealed 800 genes that were differentially expressed (with a false discovery rate 
(FDR) ≤ 0.05) in vGluT2::bacTRAP versus vGAT::bacTRAP mice, and 1,790 genes in vGluT2::bacTRAP versus 
Gad67::bacTRAP mice (Fig. 2B). The approximately two-fold lower number of significantly enriched genes in 
the comparison of vGluT2::bacTRAP versus vGAT::bacTRAP mice probably results from the lower expression 
of the eGFP-L10a transgene in the vGAT::bacTRAP line and hence a lower mRNA yield and higher variability 
in read numbers.
When we restricted the analysis to genes with an at least two-fold enrichment, comparison of the translatomes 
of vGluT2 positive and vGAT positive neurons revealed 438 differentially expressed genes. Of those, 256 genes 
were enriched in excitatory neurons, and 182 in inhibitory neurons. When the Gad67-TRAP line was used 
instead of the vGAT-TRAP line, a higher number of differentially expressed genes were detected (624, of which 
300 and 324 were enriched in excitatory and inhibitory neurons, respectively) (Fig. 2B). Between 70 and 80% of 
the differentially expressed genes identified with the vGAT-TRAP line were also found in the comparison with 
the Gad67-TRAP line (Fig. 2C), supporting the robustness of our approach.
Subsequent cluster analyses (21(http://fgcz-shiny .uzh.ch/fgcz_heatm ap_app/)) over the nine different sam-
ples revealed, as expected, that the three expression analyses made for each mouse line clustered together. As 
expected, the next hierarchical segregation separated the inhibitory (vGAT and Gad67) from the excitatory 
(vGluT2) samples. Within the inhibitory cluster vGAT samples segregated from Gad67 samples (Fig. 2D,E). The 
cluster analysis therefore identified the vGAT +,  Gad67+ and  vGluT2+ samples as three populations with distinct 
translatome profiles.
To further validate our bacTRAP approach we compared our gene expression results to recently published 
single cell sequencing data. We chose the 50 genes that were most enriched in one of the three bacTRAP lines 
employed in our study to the single cell sequencing data of Haring et al.9 (Tables S2–S5). We found that many of 
our hits were also present in the single cell data (60–70% of the 50 most enriched genes). Fourteen to 20 genes 
identified per comparison in our study were either not detected or only at a level that was too low to assign them 
to a subpopulation. Among those genes that were not detected by the single cell analysis were many transcription 
factors such as Vsx2, Lmx1b, Pax5, Barhl1 or Phox2a but also other genes (e.g. Ighg3). To verify the expression of 
some of these genes, we selected three for further investigation with in situ hybridization. We verified expression 
of Barhl1 and Phox2a, which we found enriched in excitatory cells and the immunoglobulin heavy chain gene 
Ighg3, which we surprisingly found enriched in inhibitory neurons (Fig. S2).
Finally, we were interested in the correlation of the genes highly enriched in our study with the molecular 
groups that had been defined by Haring et al.9. We therefore analyzed the distribution of the 50 most enriched 
genes among the 30 neuronal subpopulations identified by Haring et al. (Tables S2–S5). Among the genes found 
enriched in excitatory neurons in our study (Tables S2, S4), three genes (Nrn1, Cacna2d1 and Slc17a6) displayed 
expression in all 15 excitatory subtypes of Haring et al. Three other genes (Ucn3, Cpne4, Aldh1a2) have been 
attributed to only one excitatory subtype, while all other genes (44) were either attributed to more than one 
subtype or not reported in the single cell analysis. Among the genes enriched in inhibitory neurons (Tables S3, 
S5), seven genes displayed pan-inhibitory expression, seven were assigned to only one subtype and the remaining 
genes were assigned to more than one subtype or not reported. All genes that we found to be enriched in either 
inhibitory or excitatory neurons were (if detected) also exclusively or preferentially ascribed to the same cat-
egory by Haring et al. (http://linna rsson lab.org/dorsa lhorn ). This comparison suggests first that the BAC-TRAP 
approach has a lower detection limit than in the single cell RNA sequencing approach and, second, that most of 
the subpopulation specific genes detected with single cell sequencing are not only transcribed but also translated.
Figure 2.  RNA-Seq metadata from sequencing of the polysomal mRNA from vGluT2::bacTRAP, 
vGAT::bacTRAP and Gad67::BacTRAP mice. (A) Number of “expressed” genes (> 10 norm. counts) and 
number of genes with > 100 norm. counts in the three different mouse lines. (B) Number of significantly 
enriched genes (FDR ≤ 0.05) in the DGEAs between vGluT2::bacTRAP and vGAT::bacTRAP / Gad67::bacTRAP. 
Number of significantly enriched genes with ratio ≥ 2 in the excitatory and inhibitory neurons of both DGEAs. 
(C) Congruence between the enriched genes of the two DGEAs: 176 genes in common for the genes enriched 
in vGluT2 neurons and 151 genes in common for the genes enriched in the inhibitory neurons. (D,E) Cluster 
analysis with the nine mRNA samples and the genes differentially expressed in (D) vGluT2 vs. vGAT (800 
genes, FDR ≤ 0.05) and (E) vGluT2 vs. Gad67 (1790 genes, FDR ≤ 0.05). Color key indicated z-score with white 
representing zero, blue representing negative z-scores and red representing positive z-scores. (F) Subcellular 
location and (G) coarse function of the genes enriched in vGluT2 vs. vGAT and vGAT vs. vGluT2. Genes with 
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Subcellular localization and coarse function of enriched genes. To obtain a first impression what 
type of genes are enriched in inhibitory or excitatory spinal neurons we employed the Ingenuity Pathway Analy-
sis (IPA, QIAGEN) tool, which assigns a unique subcellular location (“location”) and coarse function (“type(s)”) 
to the enriched genes (Fig. 2F,G). Twenty-four percent of the genes enriched in vGluT2 over vGAT encoded 
for cytoplasmic proteins, 24% for extracellular proteins, 22% for proteins in the plasma membrane, 20% were 
nuclear proteins and the remaining 11% were located elsewhere. Similar localizations were found when genes 
enriched in the inhibitory populations were analyzed (Fig. 2F). One hundred-thirty out of 256 genes enriched in 
vGluT2 over vGAT and 109 of 182 genes enriched in vGAT over vGluT2 could be assigned to a coarse function 
(Fig. 2G). The largest group of genes that distinguished inhibitory from excitatory neurons in the adult spinal 
cord were transcription regulators (28% and 39% of the genes enriched in vGAT and vGluT2, respectively). Two 
other large molecular groups present in the set of enriched genes were enzymes and G protein coupled receptors 
(Fig. 2G).
Differential use of neurotransmitter signaling pathways. We next drew our attention to the dif-
ferential expression of genes involved in neuronal communication. As expected, we found a strong enrichment 
of genes encoding genetic markers of glutamatergic, GABAergic or glycinergic neurons (e.g. vGluT2 (Slc17a6) 
and vGluT3 (Slc17a8) in excitatory neurons, vGAT (Slc32a1), Gad67 (Gad1), Gad65 (Gad2), GAT1 (Slc6a1) and 
GlyT2 (Slc6a5) in inhibitory neurons) (Table  S1, S2–S5). However, whether other neurotransmitters such as 
serotonin or acetylcholine, which are released in the spinal cord, engage excitatory and inhibitory neurons dif-
ferentially is less clear. We used two different pathway analysis tools, PANTHER GO-term pathway  analysis22,23 
(Fig. 3 A-D) and Ingenuity pathway  analysis24 (QIAGEN Inc., https ://www.qiage nbioi nform atics .com/produ cts/
ingen uityp athwa y-analy sis) (Fig. 4A–D) to identify interneuronal signaling pathways that are enriched in either 
inhibitory or excitatory spinal neurons. Pathway analysis tools differ in the algorithms and databases they rely 
 on22–25. We used these two different pathway analysis tools to obtain a more comprehensive overview of signaling 
pathways that are enriched in either of the studied populations.
PANTHER GO-term analysis (Fig. 3A–D) indicated that Kainate selective glutamate receptor activity 
was overrepresented in the inhibitory populations (38-fold in vGAT versus vGluT2, FDR = 0.019, 21-fold in 
Gad67 versus vGluT2, FDR = 0.0497), mostly due to an enrichment of Grik1-3 expression in inhibitory neu-
rons (Tables S1, S6). In addition, terms describing acetylcholine signaling related molecular function (13–17-
fold, FDR = 0.0029–0.0171) and Gamma-aminobutyric acid transmembrane transporter activity (31.5-fold, 
FDR = 0.027) were overrepresented in inhibitory neurons.
The Ingenuity “pathway analysis” tool confirmed some the results of the GO term analyses but also identi-
fied additional receptor signaling pathways overrepresented in the different neuron populations (Fig. 4A–D). 
Glutamate and GABA receptor signaling as well as serotonin receptor signaling were overrepresented in inhibitory 
neurons (Fig. 4B,D). As expected, the enrichment of GABAergic signaling was mainly due to genes involved 
in the production (Gad1, Gad2) and transport (vGAT , Gat1) of GABA (Tables S1, S2–S5), while GABA recep-
tors showed relatively similar expression levels in the different populations (Table S8). Overrepresentation of 
Glutamate receptor signaling was due to the aforementioned enrichment of kainate receptors as well as to an 
enrichment of AMPA (Gria1), NMDA (Grin2c), and metabotropic (Grm2, Grm3) glutamate receptor subunits. 
Overrepresentation of serotonin receptor signaling (Fig. 4B) was due to the enrichment of serotonin receptors 
(Htr1a, Htr1d, Htr3a) in inhibitory neurons. Serotonin receptor 3a (Htr3a), encoding ionotropic serotonin 
receptors, was highly enriched in inhibitory spinal interneurons (Table S13) and displayed an expression pattern 
that was restricted to a population in the deep dorsal horn (Fig. S3). Tables S6–S15 illustrate relative expression 
levels and enrichment of glutamate, GABA, glycine, acetylcholine, serotonin, adrenergic, dopaminergic and 
histamine receptors. In summary, several receptor-signaling pathways are enriched within the differentially 
expressed genes, indicating that the respective neurotransmitter signaling pathways may engage inhibitory and 
excitatory spinal neurons differentially.
A neuropeptide code for glutamatergic spinal dorsal horn neurons. Neuropeptide signaling 
related terms (e.g. neuropeptide hormone activity, neuropeptide receptor activity and neuropeptide receptor bind-
ing, 4.6–26.3-fold overrepresented as compared to all expressed genes, FDR between 0.00016 and 0.0488) were 
highly overrepresented among the molecular function terms. These signaling terms were predominantly enriched 
in excitatory neurons (Fig. 3A,C). A comparison between the translatomes of the vGluT2 and Gad67 neuron 
populations demonstrated that 12 of the 50 genes most strongly enriched in excitatory neurons (Tables S2–S5) 
encoded for neuropeptides: cholecystokinin (Cck, 13.5-fold enriched in vGluT2 vs vGAT), gastrin releasing 
peptide (Grp, 8.6-fold enriched in vGluT2 vs vGAT), neuromedin B (Nmb, 18.8-fold enriched in vGluT2 vs 
vGAT), neuromedin S (Nms, 35.0-fold enriched in vGluT2 vs vGAT), neuromedin U (Nmu, 19.9-fold enriched 
in vGluT2 vs vGAT), neuropeptide FF (Npff, 43.0-fold enriched in vGluT2 vs vGAT), neurotensin (Nts, 18.0-
fold enriched in vGluT2 vs vGAT), tachykinin 2 (Tac2, encoding PPTB, the precursor of neurokinin B, 18.2-fold 
enriched in vGluT2 vs vGAT), thyrotropin releasing hormone (Trh, 7.4-fold enriched in vGluT2 vs vGAT) and 
urocortin 3 (Ucn3, 930 fold enriched in vGluT2 vs vGAT), adenylate cyclase activating polypeptide (Adcyap1, 
46-fold enriched in vGluT2 vs vGAT) and corticotropin-releasing hormone (Crh, 66-fold enriched in vGluT2 vs 
vGAT). The comparison of vGluT2 with the vGAT neurons population yielded the same 12 genes, plus in addi-
tion tachykinin 1 (Tac1, encoding PPTA, the precursor of substance P and neurokinin A, sevenfold enriched in 
vGluT2 vs vGAT), which was the 56-most enriched gene in the vGluT2–Gad67 comparison. The strong enrich-
ment and low read counts in vGAT and Gad67 samples (Tables S1, S2, S4) suggest that these neuropeptides are 
either exclusively expressed in excitatory interneurons or are present in only very few inhibitory interneurons. 
A few neuropeptides (Pnoc, NPY and Pdyn) were found enriched in inhibitory neurons. However, with only 
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Figure 3.  GO term overrepresentation analyses for the molecular function (MF) with the enriched genes in the comparison of 
vGluT2::bacTRAP to vGAT::bacTRAP and Gad67::bacTRAP. Overrepresented MF GO terms in the genes enriched in the comparison 
of (A) vGluT2 vs. vGAT, (B) vGAT vs. vGluT2, (C) vGluT2 vs. Gad67 and (D) Gad67 vs. vGluT2. (A–D) x axis displays false 
discovery rate (FDR) of the overrepresented GO term, y axis displays fold overrepresentation on a logarithmic scale and circle size 
indicates number of enriched genes. When several GO terms of a hierarchy are significantly overrepresented, only the most specific 
GO term is displayed. (D) For comprehensibility two MF are not displayed: “acetylcholine receptor activity”, 13.12-fold enrichment, 
FDR = 0.00801, no of enriched genes = 5, and “RNA polymerase II proximal promoter sequence-specific DNA binding” 2.79-fold 
enrichment, FDR = 0. 0.000603, no of enriched genes = 27.
8
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Figure 4.  Pathway analyses with the enriched genes in the comparison of vGluT2::bacTRAP to 
vGAT::bacTRAP and Gad67::bacTRAP. 15 most significantly enriched pathways within the genes enriched 
in the comparison of (A) vGluT2 vs. vGAT, (B) vGAT vs. vGluT2, (C) vGluT2 vs. Gad67 and (D) Gad67 vs. 
vGluT2. (A–D) Bar length indicates significance, color key indicates activation z-score. Orange: increased 
activity of the pathway predicted. Blue: decreased activity of the pathway predicted. White: z-score = zero or 
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three out of the 50 most enriched genes, neuropeptide enrichment was far less common in inhibitory neurons 
than in excitatory populations. In order to more deeply investigate the expression patterns of the neuropeptide-
encoding genes enriched in excitatory neurons, we employed fluorescent in situ hybridization (RNAscope). Of 
the 13 identified genes, two genes, adenylate cyclase activating polypeptide (Adcyap1) and corticotropin-releas-
ing hormone (Crh), could not be detected reliably with in situ hybridization experiments. For the remaining 11 
genes, we performed multiplex RNAscope experiments, combining up to three different neuropeptides at a time. 
Figure 5 (Fig. 5A–O) displays five of these combinations, in which every neuropeptide is represented at least 
once. Quantification of the co-expression of the depicted neuropeptides (Fig. 5C,F,I,L,O) suggested that most 
are expressed in different neuronal subtypes, yet one combination (Tac2 and Nmu) displayed a high degree of 
co-expression (Fig. 5F). To systematically determine the overlap between the different neuropeptide-expressing 
populations, we quantified for each pair of neuropeptides the percentage of co-expressing neurons. As some 
neuropeptides displayed a wide range of expression levels, we performed separate analyses either including low 
expressors (threshold near to background levels) or taking only cells into account with an expression clearly 
above background (threshold > 20 dots per cell). We created two expression matrices summarizing the percent 
of co-expressing neurons either taking only medium to high expression levels into account (Fig. 6) or all neuro-
peptide expressing neurons irrespective of the expression level (Fig. S4). Restricting the analysis to the medium 
to high expressors led to more pronounced segregations, accentuating the absence or presence of co-expression. 
When focusing on medium to high-level expression, our analyses suggested that at least eight excitatory sub-
populations are marked by either a single or a combination of several neuropeptides: 1. Npff+, 2. Grp+, 3. Tac1+, 
4. Tac2+;Nmu+, 5. Tac2+;Nmu−; 6. Nts+, 7. Cck+,Trh−,Ucn3−, 8. Cck+;Ucn3+;Trh+. Trh and Ucn3 display a high 
degree of overlap with each other (58% and 72%, respectively) and also highly overlap with Cck (86% and 91%, 
respectively). Conversely, only a minority of Cck neurons are Trh or Ucn3 positive, suggesting that the Trh and 
Ucn3 expressing neurons are a subpopulation of the Cck expressing neurons. Similarly, Nmu expressing neurons 
appear to define a subset of Tac2 positive neurons (76% of the Nmu neurons are also Tac2 positive and 25% of 
the Tac neurons are Nmu positive).
The expression patterns of several neuropeptides described above suggest a spatially restricted expression 
limited to only one or two spinal laminae (Fig. 5). To address the spatial distribution of each neuropeptide in 
more detail we imaged spinal cords at high resolution at the L3 and L4 levels. High resolution tiles were stitched, 
and the resulting images where aligned to reference sections from the spinal  cord26 (Fig. S5). We then determined 
the number of cells expressing the respective neuropeptide in each lamina. Nine out of the eleven neuropeptides 
were predominantly expressed in only one or two spinal laminae (Fig. 7A). Npff neurons were concentrated in 
lamina I, Grp, Nmu, Tac1 and Tac2 neurons were present mainly in lamina II, whereas Nts, Trh and Ucn3 neu-
rons predominated in lamina III. Cck neurons were mainly located in the deep dorsal horn (laminae III–V). In 
case of the remaining two neuropeptides, Nmb or Nms, expression patterns were weak and dispersed over most 
of the dorsal horn and were therefore not quantified. These data indicate that the different laminae of the spinal 
dorsal horn are patterned by the expression of unique combinations of only partially overlapping neuropeptide 
genes (Figs. 6, 7B).
Discussion
In this study we have characterized the mRNA translation profiles (translatomes) of inhibitory (GABA/glycin-
ergic) and excitatory (glutamatergic) spinal cord neurons. With this data we provide the first searchable dataset 
of neuron specific translatomes for the spinal cord. Pathway and Gene Ontology analyses of the translatomes 
of these two populations revealed that subtypes of neurotransmitter receptors and of down-stream signalling 
cascades differ between excitatory and inhibitory neurons and that the heterogeneity within the large population 
of excitatory dorsal horn neurons and their lamina organization is impressively mirrored by the expression of 
11 neuropeptides or neuropeptide precursors.
Correlation of transcriptome and translatome in spinal neurons. mRNA translation profiles 
obtained by the TRAP approach provide information about cell type-specific gene expression but without the 
cellular resolution obtained with single cell transcriptome profiling. However, the fraction of polysome-bound 
mRNA should more accurately reflect protein expression than approaches based on total or especially nuclear 
RNA  analyses18. This is also supported by our study. The great majority of differentially expressed genes, revealed 
in our translatome comparisons, have previously been identified as marker genes of neuron subpopulations in 
studies using single cell RNAseq. However, we also found genes enriched in inhibitory and excitatory neurons 
that were either not detected with single cell RNAseq or detected only at levels that were too low to reliably assign 
them to a subpopulation (e.g. Phox2a). Other genes may have been filtered out to reduce artefacts (e.g. cell stress 
responses) potentially introduced by the necessary dissociation of the tissue (e.g. Ighg3). Hence, the sensitivity of 
the TRAP approach appears to be at least equal to single cell RNA sequencing. At the same time, our comparison 
of the most enriched genes versus data from single cell RNA sequencing also suggests a relatively high congru-
ence between the transcriptome and the translatome. A comprehensive comparison of our translatome data with 
a recently developed harmonized transcriptional atlas of the spinal  cord27 may provide additional insights into 
the degree to which transcribed mRNAs are also translated.
Differential use of neurotransmitter and neuromodulator signaling pathways. Spinal inhibi-
tory and excitatory neurons receive synaptic inputs from a wide variety of peripheral, spinal and supraspinal 
neurons, including glutamatergic, GABAergic, glycinergic, serotonergic, cholinergic, and adrenergic neurons. 
We found that both inhibitory and excitatory spinal neurons express receptors for all these neurotransmitters 
(Tables S6–15). However, in some cases, neurotransmitter signaling appears to occur via different receptor sub-
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Figure 5.  Multiplex in situ hybridization shows co-expression of eleven neuropeptides. Five combinations of three 
neuropeptides each: (A–C) Tac1, Cck and Nts; (D–F) Nms, Nmu and Tac2; (G–I) Npff, Grp and Nmb; (J–L) Trh, Grp and 
Tac1; (M–O): Tac1, Ucn3 and Tac2 in green, red and blue, respectively. (A,D,G,J,M) Overview images over the lumbar dorsal 
horn. The outline of the gray matter is indicated. Scale bar 100 μm. Box indicates position of the higher magnification image 
in (B,E,H,K,N). (C,F,I,L,O) Number of cells per animal (two hemi-sections) that (co-)express the three neuropeptides. Circle 
and intersection sizes are approximately proportional to the cell number they represent.
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types and accordingly down-stream signaling cascades. Expression of several glutamate receptors of the kainate 
family (Grik1-3) is enriched in inhibitory spinal neurons. Kainate receptors display different modes of signal-
ing and a metabotropic action of kainate receptors has been suggested to be involved in presynaptic regulation 
and inhibition of GABA  release28,29. A preferential expression of kainate receptors on inhibitory spinal neurons 
might therefore be involved in a glutamate-mediated inhibition of GABA (and potentially glycine) release. Even 
more striking is the enrichment of several serotonin receptors on inhibitory neurons with the most pronounced 
example being Htr3a, one of the two ionotropic serotonin receptor subtypes. Expression of Htr3a is more than 
eightfold enriched in inhibitory neurons and in situ hybridization indicated expression restricted to the deep 
dorsal horn. It is therefore conceivable that serotonin released in the spinal cord from descending supraspinal 
neurons has a differential effect on excitatory and inhibitory neurons.
Lamina specific expression of neuropeptides suggests a neuropeptide code involved in modal‑
ity specific sensory processing. Our data confirm and extend previous single cell studies that identi-
fied neuropeptides as markers of excitatory neuronal  subtypes9,10. Our multiplex in situ hybridization experi-
ments demonstrate a lamina-specific distribution of many of the enriched neuropeptides with rather limited 
co-expression between different neuropeptides. In total, we find that the 11 different neuropeptides analysed in 
this study span dorsal horn laminae I–V, thus potentially setting up a map for a neuropeptide sensory signalling 
code. This is in good agreement with recent literature, as a number of these genes have either already been sug-
gested to define specific subsets of spinal  neurons11,30–32 or have already been used as driver genes for functional 
manipulation of spinal neuron  subtypes14,33–39. These studies demonstrate that neuronal subpopulations marked 
by the expression of specific neuropeptides exert modality specific functions in sensory processing. Grp+ and 
Ucn3+ neurons are required for the relay of pruriceptive  information33,37,39, Tac1+ neurons are required for pain 
associated coping behaviours, Nts+ neurons are suggested to contribute to temporal summation of nocicep-
tive input and “wide-up”34 and Cck expressing neurons are crucially involved in the development of mechani-
cal  allodynia35,38. More importantly, emerging evidence suggests that neuropeptides do not only label specific 
subtypes of spinal neurons but are themselves crucial for modality specific sensory processing. The release of 
the neuropeptides Cck and Nts has been associated with pronociceptive or antinociceptive  effects40–42. Signal-
Figure 6.  Co-expression matrix of eleven neuropeptides expressed in excitatory neurons. Co-expression within 
cells expressing a neuropeptide clearly above background levels (> 20 dots/cell). Depicted is the fraction of cells 
expressing the neuropeptide on the left, that also express the neuropeptide at the bottom. For example, 0% of the 
Nms cells, also express Npff. Color key indicates co-expression with light colors representing low co-expression 
and dark values representing high co-expression.
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Figure 7.  Laminar distribution of neuropeptides. (A) Number of cells per hemisection that express the 
depicted neuropeptide within the respective lamina of the spinal dorsal horn. Individual dots represent the 
number in a single hemisection (n = 8–10 hemisections from n = 3 mice). (B) Distribution of cells expressing the 
neuropeptide genes Npff, Grp, Tac1, Nmu, Tac2, Ucn3, Trh, Nts and Cck among the laminae of the dorsal spinal 
cord. Small dots = 2 cells, medium sized dots = 4 cells, large dots = 10 cells.
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ling via the gastrin releasing peptide (Grp), which is concentrated in lamina II, is critical for itch perception in 
 mice33,39,43,44 and required for successful signal transmission from second order Grp to third order Grp receptor 
(GRPR) positive neurons in lamina II of the spinal  cord45. Another example of a neuropeptide modulating pruri-
ceptive information at the spinal level is somatostatin (SST). We found SST to be enriched in spinal excitatory 
neurons but we also detected substantial expression in inhibitory neurons (Table S1). SST expression in inhibi-
tory dorsal horn neurons has been previously detected by Proudlock et al.46 and Haring et al.9 (see http://linna 
rsson lab.org/dorsa lhorn /) but was not reported by  others47,48. However, SST is primarily expressed in peripheral 
neurons and in excitatory lamina II dorsal horn neurons. After release of SST from peripheral sensory neurons 
or spinal dorsal horn neurons it inhibits inhibitory dynorphin (Dyn) neurons, which in turn inhibit Grp recep-
tor expressing  neurons49. SST release thereby facilitates pruriceptive signalling. In this context, it is interesting 
to note that while the majority of spinal SST expressing neurons are excitatory (glutamatergic), the effect of SST 
on Dyn neurons is inhibitory. These studies demonstrate that neuropeptides are able to add an additional layer 
of complexity to neuronal communication and may in certain cases dominate over the effect of fast-acting neu-
rotransmitters such as glutamate, GABA and glycine. The lamina specific expression of many neuropeptides in 
dorsal horn neurons suggests that distinct groups of neuropeptide expressing cells are activated by a restricted 
subset of primary afferents. Hence, distinct neuropeptides might only be released in response to certain sensory 
stimuli.
Conclusions
The present study has utilized three newly generated lines of BAC TRAP transgenic mice that allow cell type-
specific translatome analyses of excitatory glutamatergic and inhibitory GABAergic/glycinergic neurons. In the 
present study, these mice allowed us to identify several signalling pathways enriched in distinct neuron popula-
tions of the dorsal horn. Particularly interesting to us appeared an enrichment of neuropeptide signalling in 
different populations of excitatory neurons with several neuropeptides exhibiting a rather lamina specific distri-
bution suggesting an important role in modality specific sensory processing. While such a specific involvement is 
already known for some of these neuropeptides, the function of others is still obscure. The mouse lines described 
in this report and the accompanying translatome database should hence be well suited to reveal hitherto unknown 
mechanisms of normal sensory processing and their changes in disease states.
Materials and methods
Animals. Experiments were performed on 6–12-week-old mice kept at a 12:12 h light/dark cycle that received 
food and water ad libitum and were kept in a 12 h light/dark cycle. All methods were carried out in accordance 
with relevant guidelines and regulations. All animal experiments have been applied for. They have been evalu-
ated by the Commission on Animal Experimentation of the canton of Zurich. The Commission recommended 
the cantonal veterinary office (Kanton Zürich, Gesundheitsdirektion, Veterinäramt, Zollstrasse 20, CH-8090 
Zürich) to accept the respective applications. Subsequently, the cantonal veterinary office granted the following 
licenses; license ZH063/2010, ZH074/2013, ZH031/2016 and ZH011/2019. These licenses cover all experiments 
described in this study. Animal experiments were conducted adhering to the ARRIVE  guidelines50.
Generation of vGluT2::bacTRAP, vGAT::bacTRAP and Gad67::bacTRAP mouse lines. The 
vGluT2::bacTRAP mouse line was generated by placing cDNA for the eGFP-L10a (TRAP) transgene, followed by 
the bovine growth hormone polyadenylation (poly(A)) signal in frame into exon 2 of the vGluT2 (Slc17a6) gene 
(on BAC clone RPE23-84M15), using homologous recombination in  bacteria51, replacing most of exon 2 of the 
vGluT2 gene. The start codon (ATG) in exon 1 was mutated to an XhoI restriction site. For the vGAT::bacTRAP 
mouse line the transgene was placed in frame into the end of exon 1 of the vGAT (Slc32a1) gene, replacing it 
partially (on BAC clone RPE23-392P11). For the Gad67::bacTRAP mouse line the transgene was placed in frame 
into the end of exon 2 of the Gad67 (Gad1) gene, replacing it partially (on BAC clone RP24-256C12). BAC DNA 
was injected into C57BL/6 oocytes. The thereby generated mice were screened for the presence of the eGFP-
L10a transgene and for the two BAC ends by PCR. The transgenic mouse lines were maintained on a C57BL/6J 
(Black 6, The Jackson Laboratory, Stock No: 000664) background. C57BL/6J mice were also used as wild type 
controls. Mouse breeding and maintenance were provided by the Laboratory Animal Services Center (LASC) of 
the University of Zurich.
Genotyping PCRs. The presence of the eGFP-L10a transgene in the three different mouse lines was deter-
mined using a specific PCR for the transgene or a generic PCR against eGFP with one of the following primer 
pairs:




GGA AGT GCC TAA CCA CAG 
GCGT 
CTG GTT CCC GTG CAG GAC T 873 bp 56–70 °C
vGAT::bacTRAP CGA GGG TCA TGA GCC AGA GC CTG GTT CCC GTG CAG GAC T 950 bp 68 °C
Gad67::bacTRAP
CTC TCC CTT CTG TTT GCA 
GCCT 
CTG GTT CCC GTG CAG GAC T 904 bp 66 °C
eGFP 1 CTA TAT CAT GGC CGA CAA GC ACT GGG TGC TCA GGT AGT GG 164 bp 56 °C
eGFP 2 GGG CGA GGA GCT GTT CAC C
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Immunohistochemistry (IHC). For mouse line validation, adult (> 2 months old), male and female bac-
TRAP were used. Mice were transcardially perfused with approximately 20 mL of ice-cold artificial cerebrospi-
nal fluid (ACSF, pH 7.4) or phosphate buffered saline (PBS, pH 7.4), followed by 100 mL of 2 or 4% ice-cold 
paraformaldehyde (PFA, in PBS or 0.1 M Sodium phosphate buffer (PB), pH 7.4). The lumbar spinal cord was 
dissected and post-fixed for 1.5–2 h in 4% PFA solution (in PBS or 0.1 M PB, pH 7.4), followed by incubation 
in 30% sucrose (in PBS or 0.1 M PB, pH 7.4) for cryoprotection at 4 °C overnight. Cryoprotected spinal cords 
were embedded in NEG50 frozen section medium (Richard-Allen Scientific) and stored at − 80 °C until cutting 
into 25 μm thick sections on a Hyrax C60 Cryostat (Carl Zeiss). Sections were mounted on Superfrost Plus glass 
slides (Thermo Scientific, Zurich, Switzerland) and stored at − 80 °C.
For immunofluorescence staining the slides were washed for 5 min in PBS to remove the embedding medium, 
followed by blocking with 5% normal donkey serum (NDS, AbD Serotec, RRID:SCR_008898) in 0.1% Triton 
X-100-PBS for at least 30 min at room temperature (RT). Sections were incubated with primary antibodies (see 
resource table) in the blocking solution at 4 °C overnight, followed by three washes in PBS for 5 min and incuba-
tion with secondary antibodies (fluorophore-coupled donkey antibodies, Jackson ImmunoResearch) in blocking 
solution at RT for 30–60 min. Subsequently, sections were washed in PBS and incubated with 4′,6-diamidino-
2-phenylindole (DAPI, 500 ng/ml in PBS) for 10 min and again washed in PBS. Finally, sections were covered 
with DAKO fluorescent mounting medium (Dako, RRID:SCR_013530) and coverslips.
In situ hybridization (ISH). For ISHs, 6 weeks old, naïve male C57BL/6J mice were used. For spinal cord 
preparation, the vertebral column containing the lumbar part of the spinal cord were dissected, immediately 
after decapitation of the mouse. A syringe filled with ice-cold, RNAse-free PBS was fitted tightly against the 
caudal opening of the spinal canal and pressure was applied to press the spinal cord out, which was timed to the 
lumbar part. After dissection, spinal cords were snap frozen in liquid nitrogen and stored at − 80 °C until embed-
ding in NEG50 frozen section medium (Richard-Allen Scientific). Frozen blocks were again stored at − 80 °C 
until cutting into 16–25 μm thick sections and mounted as described for IHC.
For single-plex chromogenic ISH the manual RNAscope 2.5 HD BROWN Assay (ACD, Bio-Techne, catalog 
no. 322300) was used. The manufacturer’s pretreatment protocol for fresh frozen tissue (document no. 320536-
TN, rev. date 11112016) and detection protocol (document no. 322310-USM, rev. date 11052015) were followed. 
Hybridization with Amp 5 was increased from 30 to 60 min for all probes in order to increase the signal. Coun-
terstaining in 50% hematoxylin was reduced from 2 min to 30 s. Probes are listed in the resource table.
For multiplex fluorescent ISH (FISH) the manual RNAscope Multiplex Fluorescent Assay (ACD, Bio-Techne, 
catalog no. 320850) was used. The manufacturer’s pretreatment protocol for fresh frozen tissue (document no. 
320513, rev. date 11052015) and detection protocol (document no. 320293-UM, rev. date 03142017) were fol-
lowed. The fluorophore alternatives (Amp 4 Alt) were chosen in such a way, that when possible the weakest 
expressing gene would lie in red channel (Atto 550) and not in the far-red channel (Atto 647). The 3-plex negative 
control probe was amplified with the corresponding Amp 4 Alt. Probes are listed in the resource table. For every 
neuropeptide combination, one slide with four lumbar spinal cord sections of four animals, each, was reacted.
Image acquisition and analysis. Bright field imaging of ISHs and fluorescent imaging of FISHs and IHCs 
was done using the following microscopes:
Microscope Objectives Software Purpose
Zeiss Axio Scan.Z1 slidescanner
5×/0.25 Fluar air
10×/0.45 Plan-Apochromat air
ZEN 2 slidescan (blue edition)
Bright field images of chromogenic 
ISHs
Zeiss LSM710 confocal microscope
20×/0.8 Plan‐Apochromat air
40×/1.3 EC Plan‐Neofluar oil ZEN 2011 (black edition)
Fluorescent images for mouse line 
validation
Zeiss LSM700 confocal microscope
25×/0.8 Plan‐Neofluar oil
40x/1.4 LCI Plan-Apochromat oil
Zen 2011 (black edition) Overview images of multiplex FISH




ZEN 2.3 (blue edition)
Overview and analysis images of 
multiplex FISH
For fluorescent imaging, the pinhole was set to 1 airy unit for every channel, which were scanned sequentially 
to avoid overlapping emission spectra or with a combination of the ultraviolet and infrared channel in one track, 
where emission spectra overlap is minimal.
For the validation of the correct expression of the eGFP-L10a transgene, the 40× objectives on the LSM 
700 or 710 were used with a zoom of 0.6× to acquire a tile scan over the complete lumbar dorsal horn (Pixel 
size: × 0.346 μm, y 0.346 μm, z 1.628/2.487 μm). A small z-stack (usually, 3.3 μm within 3 optical sections) at a 
bit depth of 8 was acquired. For the analysis, the cell counter plugin of ImageJ was used. Manual counting was 
done in the middle optical section; the other sections were used as an aid to distinguish between neighboring 
cells. Three hemi-sections from three animals of each mouse line were analyzed. Ratios were calculated per 
animal and then averaged.
For the quantification of the co-expression of the neuropeptides with multiplex FISH, the 40× objective on the 
LSM 800 was used with a zoom of 2× and an image size of 1024 × 1024 px (pixel size: × 0.078 μm, y 0.078 μm). An 
array of non-overlapping images that covers the complete dorsal horn was scanned at a bit depth of 16. Analysis 
was done with CellProfiler 2.2.0  software52. The cell profiler pipeline can be provided upon request. Briefly, nuclei 
were detected using the IdentifyPrimaryObjects module and expanded with the IdentifySecondaryObjects module 
to define the cell soma (from now on referred to as “cell”). The signal dots were detected using the IdentifyPri-
maryObjects module, adapting the “threshold correction factor” and the “lower and upper bounds on threshold” 
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for every slide (neuropeptide combination) to minimize false positive and false negative detection. The signal 
dots of the different channels were assigned to the cells they lie in using the RelateObjects module. The number 
of cells and related signal dots (per channel) were exported using the ExportToSpreadsheet module. Images with 
artefacts or high background were manually excluded from the automatic analysis in order to avoid false positive 
signal. Per slide (neuropeptide combination), three animals with two hemi-sections per animal were analyzed. 
Additionally, per combination one hemi-section hybridized with the 3-plex negative control probe and amplified 
with the same Amp 4 Alt was imaged with the same microscope setting and analyzed with the same CellProfiler 
setting in order to determine the background.
Data analysis was conducted with R. To determine the signal background, the 3-plex negative control was 
analyzed. For every combination and channel, the 90th percentile of dots per cell in the negative control was 
determined. This value was set as the threshold above which a cell is counted as positive for the respective signal. 
20 dots per cell were set as a threshold for high expression. The number of single, double and triple-positive cells 
was counted. Ratios were calculated per animal and then averaged.
Cell‑type‑specific polysomal mRNA isolation from excitatory and inhibitory spinal cord neu‑
rons. To specifically isolate polysomal mRNA from genetically targeted cells, the three bacTRAP mouse 
lines described above were used and the protocol published by Heiman, et al.53 was followed. In brief, solutions 
and the affinity matrix were prepared as described. For the affinity matrix of Gad67::bacTRAP 300 μL and of 
vGluT2::bacTRAP and vGAT::bacTRAP 150 μL Streptavidin MyOne T1 Dynabeads and the corresponding vol-
umes of biotinylated protein L and GFP antibodies 19C8 and 19F7 were used in a final volume of 200 μL.
Per mouse line three male mice per mouse line, aged between 8 and 10 weeks were used. The vertebral col-
umn containing the lumbar part of the spinal cord was dissected, immediately after decapitation. A syringe filled 
with ice-cold dissection buffer was fitted tightly against the caudal opening of the spinal canal and pressure was 
applied to press the spinal cord out, which was trimmed to the lumbar part. For the neuropathic pain analysis, 
the lumbar spinal cord was bisected along the midline and the left side (ipsilateral to the peripheral nerve sur-
gery) was further processed. The tissue was washed, homogenized, centrifuged, lysed and again centrifuged as 
described in the protocol by Heiman et al.53.
Immunopurification was done as described by Heiman et al.53. RNA purification was done using the RNeasy 
Plus Micro Kit (Qiagen, catalog no. 74034). RNA was eluted from beads with 350 μl Buffer RLT Plus from the kit, 
supplemented with 40 μM dithiothreitol (DTT, Thermo Fisher Scientific, catalog no. R0861) and then processed 
according to the manufacturer’s protocol. RNA concentration was determined using the RiboGreen fluorescence 
assay (Thermo Fisher Scientific, catalog no. R11491) on a NanoDrop 3300 microvolume fluorospectrometer. 
RNA quality was assessed by high sensitivity RNA screen tape on an Agilent 2200 TapeStation. RNA samples 
with RINe values of 6.8–7.8 were used for sequencing library construction.
Sequencing library construction, next‑generation sequencing (NGS), mapping and differen‑
tial gene expression analysis (DGEA). The sequencing library was prepared using the Ovation Mouse 
RNA-Seq System 1–16 kit (NuGEN, catalog no. 0348-32). The manufacturer’s protocol was followed. 13–20 ng 
RNA were used as input material for the inhibitory—excitatory comparison and 30 ng RNA for the neuropathic 
pain analysis. The optional cDNA fragmentation step was performed on a Covaris S220 focused-ultrasonicator 
(Covaris) to obtain a median fragment size of approx. 300 bp. As recommended, the optimal cycle number for 
amplification was determined by qPCR (cycle number within the exponential phase of the amplification plot) 
and turned out to be 18.
Sequencing of the library, mapping to the reference genome, as well as DGEA were performed by the Func-
tional Genomics Center Zurich (FGCZ). NGS was done on two lanes of a HiSeq 2500 system (illumina) with 
single-end sequencing of 125 bp. Mapping was done in R using the STAR package, version 2.4.2a [68]. The refer-
ence genome build Mus_musculus Ensembl GRCm38 release 80 was used for alignment. Reads mapped to exons 
were counted using countOverlaps in GenomicRanges version 1.20.5 (parameters: countNonredundant = TRUE, 
minFeatureOverlap = 10, minMapQuality = 10, keepMultiHits = TRUE)54. DGEA was done in R using either the 
package edgeR 3.10.2 or DESeq2 1.8.1 [69–71]. Bioinformatic analysis was performed using the R package ezRun 
(https ://githu b.com/uzh/ezRun ) within the data analysis framework  SUSHI55. Quality  checkpoints56, such as 
quality control of the alignment and count results, were implemented in ezRun (https ://githu b.com/uzh/ezRun 
) and applied throughout the analysis workflow to ensure correct data interpretation. In details, read alignments 
were comprehensively evaluated using the RnaBamStatsApp (https ://githu b.com/uzh/ezRun /blob/maste r/R/app-
RnaBa mStat s.R) in the ezRun package, in terms of different aspects of RNA-seq experiments, such as sequence 
quality, gDNA and rRNA contamination, GC/PCR/sequence bias, sequencing depth, strand specificity, coverage 
uniformity and read distribution over the genome annotation. Gene counts were comprehensively evaluated 
using the CountQCApp (https ://githu b.com/uzh/ezRun /blob/maste r/R/app-count QC.R) in the same R package, 
including sample correlation, sample clustering, as well as clustering of high variance features.
Gene Ontology (GO) term and pathway enrichment analyses. GO term enrichment analysis was 
done using the online PANTHER tool (http://panth erdb.org/). Genes significantly (FDR ≤ 0.05) and ≥ 2-fold 
enriched in excitatory (vGluT2) over inhibitory (vGAT or Gad67) and vice versa were analyzed. In the PAN-
THER overrepresentation test, the sets of enriched genes were compared to the set of all expressed genes as a 
reference. GO molecular function (MF) complete was used as the annotation data set. The significantly over-
represented (FDR ≤ 0.05) MFs were analyzed. When several GO terms of a hierarchy were significantly over-
represented, only the most specific GO term was displayed in the graphical representation. For the analysis of 
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Gad67 vs. vGluT2, two redundant GO terms were not displayed in the graphical representation in order to allow 
comprehensibility.
Pathway analysis was done with Ingenuity Pathway Analysis (IPA, QIAGEN). Genes significantly (FDR ≤ 0.05) 
and ≥ 2-fold enriched in excitatory (vGluT2) over inhibitory (vGAT or Gad67) and vice versa were analyzed. To 
get a coarse classification of the enriched genes into subcellular location and function (“type”), these parameters 





R & D Systems (Minneapolis, 
MN, USA)
RRID:AB_10889828
guinea pig anti-Lmx1b (1:10,000) Dr. Carmen Birchmeier 57
rabbit anti-GFP (1:2000) Molecular Probes RRID:AB_221570
mouse anti-NeuN (1:1000) Millipore RRID:AB_2298772
guinea pig anti-NeuN (1:1000) SynapticSystems RRID:AB_2619988
RNAscope multiplex FISH probes
Mm-Cck ACD, Bio-Techne 402271
Mm-Grp ACD, Bio-Techne 317861
Mm-Grp-C2 ACD, Bio-Techne 317861-C2
Mm-Nmb ACD, Bio-Techne 459931
Mm-Nmb-C3 ACD, Bio-Techne 459931-C3
Mm-Nms ACD, Bio-Techne 472331
Mm-Nms-C3 ACD, Bio-Techne 472331-C3
Mm-Nmu ACD, Bio-Techne 446831
Mm-Npff ACD, Bio-Techne 479901
Mm-Nts-C2 ACD, Bio-Techne 420441-C2
Mm-Tac1-C3 ACD, Bio-Techne 410351-C3
Mm-Tac2 ACD, Bio-Techne 446391
Mm-Tac2-C2 ACD, Bio-Techne 446391-C2
Mm-Trh ACD, Bio-Techne 436811
Mm-Ucn3 ACD, Bio-Techne 464861
Mm-Barhl1 ACD, Bio-Techne 520561
Mm-Phox2a ACD, Bio-Techne 520371
Mm-Ighg3 ACD, Bio-Techne 514611
Positive control probe Mm-Ppib ACD, Bio-Techne 313911
Negative control probe-DapB ACD, Bio-Techne 310043
3-plex negative control probe ACD, Bio-Techne 320871
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